Literature DB >> 8745426

Development of fetal movement--fetal heart rate coupling from 20 weeks through term.

J A DiPietro1, D M Hodgson, K A Costigan, S C Hilton, T R Johnson.   

Abstract

This study documents the development of fetal heart rate (FHR) change in response to fetal movement (FM) in healthy fetuses from 20 weeks' gestational age through term. Thirty-one fetuses received 50 min of Doppler-based monitoring at 20, 24, 28, 32, 36 and 38-39 weeks. FHR and FM were continuously digitized. A coupling index was computed as the percentage of FMs associated with increases in FHR of 5 beats/min or more within -5 or +15 s of movement onset. The latency between FM onset and FHR change was also computed, as were the amplitude and duration of all movements. FM and FHR became more integrated with advancing gestation. Coupling increased and the latency between FM and FHR changes decreased. Maternal age, blood pressure and fetal sex did not affect FM-FHR coupling, but fetuses of women who reported greater stress in their daily lives and had faster heart rates displayed reduced coupling. These data suggest that the development of FM-FHR coupling reflects the development of the central nervous system during gestation, and that development may be affected by maternal factors.

Entities:  

Mesh:

Year:  1996        PMID: 8745426     DOI: 10.1016/0378-3782(95)01704-6

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  24 in total

1.  STUDIES IN FETAL BEHAVIOR: REVISITED, RENEWED, AND REIMAGINED.

Authors:  Janet A DiPietro; Kathleen A Costigan; Kristin M Voegtline
Journal:  Monogr Soc Res Child Dev       Date:  2015-09

2.  Fetal heart rate patterns at 20 to 24 weeks gestation as recorded by fetal electrocardiography.

Authors:  F Hofmeyr; C A Groenewald; D G Nel; M M Myers; W P Fifer; C Signore; G D V Hankins; H J Odendaal
Journal:  J Matern Fetal Neonatal Med       Date:  2013-10-31

3.  Prenatal antecedents of newborn neurological maturation.

Authors:  Janet A DiPietro; Katie T Kivlighan; Kathleen A Costigan; Suzanne E Rubin; Dorothy E Shiffler; Janice L Henderson; Joseph P Pillion
Journal:  Child Dev       Date:  2010 Jan-Feb

4.  Fetal responses to induced maternal relaxation during pregnancy.

Authors:  Janet A DiPietro; Kathleen A Costigan; Priscilla Nelson; Edith D Gurewitsch; Mark L Laudenslager
Journal:  Biol Psychol       Date:  2007-08-31       Impact factor: 3.251

5.  Dyadic Intervention during Pregnancy? Treating Pregnant Women and Possibly Reaching the Future Baby.

Authors:  Sharone Bergner; Catherine Monk; Elizabeth A Werner
Journal:  Infant Ment Health J       Date:  2008

6.  Maternal prenatal stress phenotypes associate with fetal neurodevelopment and birth outcomes.

Authors:  Kate Walsh; Clare A McCormack; Rachel Webster; Anita Pinto; Seonjoo Lee; Tianshu Feng; H Sloan Krakovsky; Sinclaire M O'Grady; Benjamin Tycko; Frances A Champagne; Elizabeth A Werner; Grace Liu; Catherine Monk
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

Review 7.  Impact of maternal stress, depression and anxiety on fetal neurobehavioral development.

Authors:  Michael T Kinsella; Catherine Monk
Journal:  Clin Obstet Gynecol       Date:  2009-09       Impact factor: 2.190

Review 8.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

9.  Effects of docosahexaenoic acid supplementation during pregnancy on fetal heart rate and variability: a randomized clinical trial.

Authors:  K M Gustafson; S E Carlson; J Colombo; H-W Yeh; D J Shaddy; S Li; E H Kerling
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-02-20       Impact factor: 4.006

Review 10.  Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic pathways.

Authors:  Catherine Monk; Julie Spicer; Frances A Champagne
Journal:  Dev Psychopathol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.